Loading organizations...
ViuHealth delivers a digital health platform specializing in comprehensive autoimmune care management. The company provides personalized solutions, including a dedicated app, to assist individuals in understanding and mitigating autoimmune disease triggers, reducing flare-ups, and managing their overall well-being. Functioning as a population health and real-world evidence platform, ViuHealth also focuses on enhancing diverse patient representation within clinical research.
The company was co-founded in 2019 by Kwaku Owusu and Melanie Igwe, initially under the name DrugViu. Their foundational insight stemmed from identifying a critical gap in clinical trial diversity, which often leads to inadequate healthcare outcomes for underrepresented populations. This realization drove them to build a platform that addresses these disparities directly.
ViuHealth serves patients living with various autoimmune conditions, empowering them through simplified, day-to-day management and tailored support. Its overarching vision is to enable these individuals to lead fulfilling lives by offering accessible, personalized care while actively working to foster more inclusive and equitable healthcare representation for all patient communities.
ViuHealth has raised $200K across 1 funding round.
ViuHealth has raised $200K in total across 1 funding round.
ViuHealth is a technology company that builds a holistic virtual care platform specifically designed for individuals with autoimmune diseases. It offers a remote care application that connects patients with a dedicated clinical care team—including nurse practitioners, registered nurses, and certified health coaches—to provide personalized health coaching, symptom tracking, and management tools. The platform serves both patients and physicians by improving daily disease management, reducing flares, and supporting care between doctor visits. ViuHealth’s solution also enables physicians to expand virtual care offerings and uncover new reimbursement opportunities, contributing to better patient outcomes and practice revenue growth[1][3][4].
Founded in 2018 (initially as DrugViu), ViuHealth evolved from a real-world evidence (RWE) and clinical research platform focused on improving diverse patient representation in autoimmune clinical trials to a broader care management platform. The company rebranded to ViuHealth in 2022 to reflect its shift toward providing comprehensive digital care solutions beyond pharmaceutical treatments. Its CEO, Kwaku Owusu, leads the company from its New York City headquarters. Early pivotal moments include partnerships with organizations like The Leaders Rheum and Coral Genomics to enhance rheumatology care and minority patient outcomes in inflammatory bowel disease[1][2].
ViuHealth rides the growing trend of digital health and virtual care, particularly in chronic disease management. The timing is critical as autoimmune diseases require continuous, personalized care that traditional episodic physician visits cannot fully address. Market forces such as increased telehealth adoption, demand for patient-centered care, and healthcare reimbursement reforms favor platforms like ViuHealth. By partnering with specialists and leveraging technology, ViuHealth influences the ecosystem by improving patient outcomes, supporting independent practices, and advancing inclusive clinical research[1][2][3].
ViuHealth is poised to expand its impact by deepening partnerships with rheumatology providers and broadening its patient base. Trends shaping its journey include the rise of personalized medicine, integration of real-world data in clinical decision-making, and increasing demand for virtual chronic care solutions. Its influence may evolve toward becoming a standard adjunct to autoimmune care, driving better health outcomes and reshaping how chronic autoimmune diseases are managed digitally.
In summary, ViuHealth’s transformation from a clinical trial recruitment platform to a comprehensive autoimmune care management solution highlights its commitment to improving patient lives through technology and personalized care.
ViuHealth has raised $200K in total across 1 funding round.
ViuHealth's investors include Techstars Impact Fund.
ViuHealth has raised $200K across 1 funding round. Most recently, it raised $200K Seed in May 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2019 | $200K Seed | — | Techstars Impact Fund | Announced |